There was just a new site opened for the early/expanded access program for Alpharedin (Radium-235). The new site is at Stanford University, California. This makes a total of four sites, but most of them have not been adequately supported by the drug company, Bayer. Hopefully, this site will be better supported, but if it too [...]
It is the general consensus that prostate cancer when still confined to the prostate gland is gland curable, but when it has left the prostate gland and becoming metastatic it is no longer curable. But evidence now says there might be an intermediate stage where the cancer has spread outside the prostate gland but is [...]
Powdered turmeric is a common ingredient of Indian food and a substance that has been used for centuries to treat osteoarthritis and other illnesses. In March 2012 researchers from Michigan State University found that curcumin may be beneficial for people with Parkinson's disease as well as head and neck cancers. It is now thought that [...]
Fall is quickly approaching, along with the colors it also brings the influenza. For most people influenza is a bother, but for cancer survivors it brings many unique concerns not shared with the general population. It brings serious illness, hospitalizations and possibly death! During an influenza epidemic, between 21% and 33% of cancer survivors who [...]
One of the constant complaints I hear fro men with advanced prostate cancer that has become castrate resistant about Provenge (sipuleucel-T) is that the anticipated increase in overall survival is only 4.1 months and given the cost of $93,000 for the three infusions many men feel that cost does not justify the survival benefit. My [...]